Clinical Decision Tool Cuts Inappropriate BMA Therapy in Prostate Cancer

(MedPage Today) -- SAN DIEGO--An algorithm-based decision tool eliminated inappropriate prescribing of bone-modifying agents (BMA) in patients with advanced prostate cancer, according to a VA-based study.
Prior to implementing the tool, inappropriate...